At-Home Cancer Treatment Compared to In-Clinic Treatment for Patients with Advanced Cancer

Sponsor: Mayo Clinic

Sponsor score: 60
Inactive

ClinicalTrials ID:NCT05969860

Provider View

This study is exploring whether receiving cancer treatment at home is as effective as receiving it in a clinic for patients with advanced cancer. The goal is to see if at-home treatment can reduce stress and improve quality of life for patients and their families.

Patient Parameters

Program Overview

This clinical trial is investigating the effects of receiving cancer treatment at home versus in a clinic for patients with advanced cancer, which means the cancer has spread to nearby tissues or other parts of the body. Currently, most cancer treatments are given in hospitals or clinics, which can be stressful and costly for patients and their families. This study aims to see if at-home treatment can help reduce these burdens and improve patients' quality of life. By providing treatment at home, the study hopes to make it easier for patients to stick to their treatment plans, especially for those in underserved communities.

Description

The main goal of this study is to compare how patients feel about their access to cancer care when receiving treatment at home versus in a clinic. Patients will be asked about their preferences and comfort levels with home treatment after 24 weeks. The study will also look at whether patients find home treatment worthwhile and if they would recommend it to others. Researchers will assess if home treatment improves patients' overall health and quality of life compared to clinic treatment. They will also monitor any side effects and check if home treatment reduces emergency room visits or hospital stays.

Participants will start with two cycles of their usual chemotherapy in the clinic. Then, they will be randomly assigned to one of two groups:

  • Group A: Continue receiving chemotherapy at home for about 24 weeks, with home health nurses providing care and monitoring through devices and video visits.
  • Group B: Continue receiving chemotherapy in the clinic for about 8 weeks, then switch to home treatment like Group A for about 16 more weeks.

After the study, patients will be followed for one year to monitor their health and treatment outcomes.

Eligibility Criteria

Inclusion Criteria

  • Adults aged 18 or older with a confirmed cancer diagnosis.
  • Currently receiving specific chemotherapy treatments for various cancers, such as bladder, lung, pancreatic, breast, and others.
  • Have tolerated their current chemotherapy well, with no severe reactions.
  • Live within 35 miles of the clinic or in an area served by the study's network.
  • Have a reliable internet connection at home.
  • Able to understand and complete study questionnaires.
  • Have a performance status indicating they are fully active or have some restrictions but can still perform light work.
  • Agree to participate and follow the study protocol.

Exclusion Criteria

  • Receiving any other experimental cancer treatments.
  • Need 24/7 assistance with daily activities.
  • Currently hospitalized (except for specific home care programs).
  • Have severe health conditions that could interfere with the study.
  • Have had a severe infection or hospitalization for infection complications within the last four weeks.
  • Expect to need major surgery during the study period.

Get This Program In Your Inbox

Receive detailed information about this treatment opportunity to review with your healthcare provider.